Diamedica Therapeutics Inc. (DMAC) — DEF 14A Filings
All DEF 14A filings from Diamedica Therapeutics Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
DiaMedica Therapeutics Files 2025 Proxy Statement
— Mar 28, 2025 Risk: low
DiaMedica Therapeutics Inc. filed its definitive proxy statement (DEF 14A) on March 28, 2025, for the fiscal year ending December 31, 2024. The filing pertains -
DiaMedica Therapeutics Inc. Announces 2024 Annual General Meeting of Shareholders
— Apr 4, 2024 Risk: low
DiaMedica Therapeutics Inc. (DMAC) filed a Proxy Statement (DEF 14A) with the SEC on April 4, 2024. The 2024 Annual General Meeting of Shareholders for DiaMedic
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX